found an overall decrease of jejunal GLP‐1 secreting cells in obesity, but subjects in their lean control group were older and composed of patients with gastric or pancreatic tumor and signs of hepatic and systemic inflammation, these conditions possibly affecting the intestinal endocrine cells. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.